Sign in

CIK 0000812796 · Non-accelerated filer<br>Smaller reporting company

SOLIGENIX, INC.

Sign in to watch
Ticker
SNGX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
411505029
Phone
609-538-8200
Business address
29 EMMONS DRIVE, SUITE B-10, PRINCETON, NJ, 08540
Former names
SOLIGENIX, INC., DOR BIOPHARMA INC, ENDOREX CORP, IMMUNOTHERAPEUTICS INC
  1. 8-K Event Material agreement
  2. S-1 Offering Registration Statement
  3. 8-K Event Material agreement · Unregistered share sale
  4. 8-K Event Shareholder rights changed · Executive or director change · Bylaws or fiscal year change · Shareholder vote results · Regulation FD disclosure
  5. DEFA14A Proxy Proxy Materials
  6. DEFA14A Proxy Proxy Materials
  7. 8-K Event Shareholder vote results · Regulation FD disclosure
  8. DEFA14A Proxy Proxy Materials
  9. 8-K Event Other events
  10. DEFA14A Proxy Proxy Materials
  11. DEFA14A Proxy Proxy Materials
  12. 424B3 Offering Prospectus
  13. 10-Q Report Quarterly Report
  14. ARS Other Annual Report to Security Holders
  15. DEF 14A Proxy Proxy Statement
  16. 8-K Event Material agreement · Other events
  17. PRE 14A Proxy Proxy Statement (Preliminary)
  18. 424B4 Offering Prospectus
  19. EFFECT Other Notice of Effectiveness
  20. CORRESP Other Correspondence Between Filers and SEC Staff

Page 7 of 72 · 1,429 filings